Aghazadeh Behzad

Director · Other reporting person · Ten-percent owner · SCTX, WHWK, AADI

As of 2026-09-16, Aghazadeh Behzad has 7 Form 4 transactions on record across 3 companies — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $582KIndirect: $104.1M$104.7Mas of 2026-09-16
  • Direct $582K
  • Indirect $104.1M
SCTXindirect3,088,888 sh$89.9M
AADIindirect8,333,000 sh$14.2M
SCTXdirect14,725 sh$428K
WHWKdirect38,040 sh$154K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

SCTX · 4 trades
2026-07-28: Purchase, 7,905 sh ($144K)2026-07-24: Purchase, 2,333,333 sh ($35.0M)2026-07-24: Purchase, 50,000 sh ($1.1M)2026-07-23: Award / grant, 14,725 sh ($0)
WHWK · 2 trades
2026-06-12: Award / grant, 38,040 sh ($0)2025-06-12: Award / grant, 40,006 sh ($0)
AADI · 1 trade
2025-02-28: Award / grant, 8,333,000 sh ($20.0M)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-07-28SCTXPurchase7,905 @ $18.25$144K+0.3% of holding3,088,888Form 4
2026-07-24SCTXPurchase2,333,333 @ $15.00$35.0M+334.5% of holding3,030,983Form 4
2026-07-24SCTXPurchase50,000 @ $22.31$1.1M+1.6% of holding3,080,983Form 4
4 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-07-23SCTXAward / grant14,72514,725Form 4
2026-06-12WHWKAward / grant38,04038,040Form 4
2025-06-12WHWKAward / grant40,00640,006Form 4
2025-02-28AADIAward / grant8,333,0008,333,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.